Our Services Turn Ideas into Outcomes

Colbert et al. delivers agile, PhD-level consulting for biotech, AI, and digital health ventures, without the overhead of full-time hires. Whether you're designing a pivotal trial, preparing for investor outreach, or exploring new verticals, we operate as an extension of your team to accelerate outcomes with precision support and the impact of technical insight converted into measurable progress.

Business meeting in a conference room with a man giving a presentation to a group of six people seated around a large table with laptops and gift bags, sunlight coming through windows.

Learn about our services

  • We translate complex science into executable development plans that withstand regulatory and investor scrutiny. Our team has designed target-product profiles, pre-IND/IDE roadmaps, and late-phase study blueprints for everything from prescription digital therapeutics to novel biologics and hybrid drug-device platforms.

    Key offerings

    • Target Product Profiles (TPPs) and indications strategy

    • Phase I–III protocol design and endpoint selection

    • Regulatory briefing packages and meeting preparation (FDA, EMA, etc.)

    • Literature gaps analyses and mechanistic rationale build-outs

    • Scientific advisory board curation and moderation

  • Turning raw clinical and real-world data into decision-grade insight is our specialty. We build reproducible workflows that uncover cost offsets, dose-response signals, and predictive markers, and then package the findings in clear visual stories for executives, investors, and regulators.

    Key offerings

    • Real-world evidence (RWE) study design and statistical analysis

    • Outcomes dashboards for RPM, digital health, and traditional trials

    • Health-economic & budget-impact models (payer-ready)

    • Dose-optimization algorithms and adaptive-design simulations

    • Data-driven manuscripts, posters, and investor visuals

  • Compelling data deserves compelling presentation. We transform complex findings into clear, visually engaging narratives that resonate with regulators, clinicians, investors, and patients alike, elevating your scientific credibility and market presence.

    Key offerings

    • Manuscript development, ghost-writing, and journal submission support

    • Grant writing, applications and registrations for federal and private grants

    • Abstracts, posters, and slide decks for major congresses

    • Investor and board presentation design (storyboarding, graphics, speaker notes)

    • Infographics, one-pagers, white pages and social-media assets for data dissemination

    • Brand-aligned scientific style guides and template libraries, cover illustrations, graphic design support

    • Cross-functional review management (medical, legal, regulatory)

  • Great science fails without a clear commercial runway. We craft evidence-backed launch strategies that resonate with payers, providers, and patients, combining HEOR analytics, pricing logic, and frontline stakeholder insights.

    Key offerings

    • Pricing & reimbursement strategy (US, EU, ex-US)

    • Budget-impact & cost-effectiveness models

    • KOL & payer advisory boards

    • Launch sequencing and channel strategy

    • Value-dossier creation and objection-handling playbooks

    • Health economics and outcomes research (HEOR)

  • Whether you need co-development partners, licensing opportunities, or investor traction, we extend your reach and sharpen your pitch. Our systematic outreach funnels and negotiation support convert cold prospects into warm deals.

    Key offerings

    • Target identification & short-list refinement (VCs, biopharma, CROs)

    • Outreach scripting, collateral, and list management

    • Conference meeting scheduling & follow-up coordination

    • Term-sheet benchmarking and negotiation coaching

    • Partner diligence summaries and risk assessments

  • We help leadership teams allocate capital and talent where it matters most. Whether you manage a single asset or a platform of candidates, our structured framework ranks opportunities, de-risks pivots, and arms you with investor-grade storytelling.

    Key offerings

    • Asset scoring & valuation scenarios (kill-keep-pivot)

    • Competitive landscape & white-space mapping

    • Integrated development timelines and resource planning

    • Talent and organizational design for R&D scale-up

    • Fundraising narratives and diligence data rooms

  • No off-the-shelf template fits every challenge. So, we build bespoke engagements that fill critical gaps, from scientific storytelling to operational execution across borders.

    Key offerings

    • Scientific communication packages (posters, slide decks, abstracts)

    • Conference strategy & booth/virtual presence management

    • Cross-border operational setup (e.g., EU/US site activation)

    • Patient-engagement tools and educational assets

    • Rapid literature and competitive sweeps for time-sensitive decisions

    • Government contract organizations support

Select Impact

Client Outcomes That Speak for Themselves

  • +25% trial enrollment: Site-level protocol optimization for Phase 3 pivotal trial

  • Partnerships closed: From universities to health systems and pharma pilots

  • Successful investor outreach: Strategic narrative, deck design, VC targeting for early-stage ventures

  • Doubled pitch-to-meeting conversion: Fractional support for digital health accelerator clients

  • Extensive peer-reviewed publications with 10+ conference posters: Scientific communication strategy and execution

  • $10M ARR growth: RPM expansion strategy, outcomes reporting, and GTM messaging leading to increased ARR

From trial recovery to vertical expansion, these results reflect our hands-on, PhD-led approach.

“We now close every deal with the data and decks generated by Colbert et al., adding $10M in ARR.”
— CSO, RPM Company
Corporate incubator office

Submit an Inquiry

Deploy a global network of PhDs, MDs, and AI specialists, precisely when and where you need them. Scale your strategic, technical, and operational goals without full-time overhead, at a fraction of the cost of a single hire.